# Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]

> **NCT00490022** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 31 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Dihydrotestosterone (DHT) gel (0.7%)
- **DRUG:** Placebo gel

## Key facts

- **NCT ID:** NCT00490022
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2011-06-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00490022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00490022, "Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00490022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*